A new mechanistic insight into the association between environmental perfluorooctane sulfonic acid (PFOS) exposure and attention deficit and hyperactivity disorder (ADHD)-like behavior

Neurotoxic effects of chronic exposure to perfluorobutane sulfonate in adult zebrafish (Danio Rerio)

Per and polyfluoroalkyl substances (PFAS) are synthetic compounds extensively utilized in industrial applications and consumer products. Long-chain PFAS has been linked to negative health impacts, prompting the introduction of shorter-chain alternatives like perfluorobutane sulfonate (PFBS). While long-chain PFAS are known to induce oxidative stress, neuroinflammation, and neuronal apoptosis, the neurotoxic potential of short-chain PFAS like PFBS was not well studied. This study aims to evaluate the neurotoxic effect and bioaccumulation of PFBS on adult zebrafish. In this study, adult zebrafish were exposed to PFBS at concentrations of 0.14, 1.4, and 14 μM for 28 days. PFBS accumulation in zebrafish brain tissue was confirmed by specific mass spectrum peaks. Behavioral assays revealed significant anxiety-like behavior, with PFBS (14 μM) exposed zebrafish spending more time in the bottom zone of the novel tank diving test (179.33 ± 1.03 s) and in the light and dark preference results showed increased time spent in the dark zone (165.17 ± 10.89 s). Learning and memory deficits were evident in the T-maze test, where PFBS-exposed zebrafish spent less time in the favorable zone (0.67 ± 1.15 s). Biochemical analysis showed significant inhibition of acetylcholinesterase (AChE) activity in the male and female brains (0.06 μmol/min and 0.09 μmol/min). Antioxidant enzyme levels were reduced, with superoxide dismutase (SOD) 5.45 U/mg protein in the male brain and 4.06 U/mg protein in the female brain, leading to increased oxidative stress biomarkers like lipid peroxidation and nitric oxide levels in male (0.99 μmol/mg/ml and 8.85 μM) and female brain (1.83 μmol/mg/ml and 8.74 μM), respectively. Gene expression analysis demonstrated the downregulation of SOD, CAT, GSR, and GPx, indicating impaired antioxidant defense mechanisms. Histopathological analysis of PFBS exposure groups revealed vacuolation and increased pyknotic neurons in the optic tectum region of the brain. Our study suggests that PFBS exposure leads to bioaccumulation in the brain, causing histopathological changes and cognitive impairment. In conclusion, PFBS induces neurotoxicity which can be a potential risk as they are incorporated into a range of consumer products.

Zebrafish models for studying cognitive enhancers

Cognitive decline is commonly seen both in normal aging and in neurodegenerative and neuropsychiatric diseases. Various experimental animal models represent a valuable tool to study brain cognitive processes and their deficits. Equally important is the search for novel drugs to treat cognitive deficits and improve cognitions. Complementing rodent and clinical findings, studies utilizing zebrafish (Danio rerio) are rapidly gaining popularity in translational cognitive research and neuroactive drug screening. Here, we discuss the value of zebrafish models and assays for screening nootropic (cognitive enhancer) drugs and the discovery of novel nootropics. We also discuss the existing challenges, and outline future directions of research in this field.

Lipid responses to perfluorooctane sulfonate exposure for multiple rat organs

Perfluorooctane sulfonate (PFOS) is a persistent chemical that has long been a threat to human health. However, the molecular effects of PFOS on various organs are not well studied. In this study, male Sprague-Dawley rats were treated with various doses of PFOS through gavage for 21 days. Subsequently, the liver, lung, heart, kidney, pancreas, testis, and serum of the rats were harvested for lipid analysis. We applied a focusing lipidomic analytical strategy to identify key lipid responses of phosphorylcholine-containing lipids, including phosphatidylcholines and sphingomyelins. Partial least squares discriminant analysis revealed that the organs most influenced by PFOS exposure were the liver, kidney, and testis. Changes in the lipid profiles of the rats indicated that after exposure, levels of diacyl-phosphatidylcholines and 22:6-containing phosphatidylcholines in the liver, kidney, and testis of the rats decreased, whereas the level of 20:3-containing phosphatidylcholines increased. Furthermore, levels of polyunsaturated fatty acids-containing plasmenylcholines decreased. Changes in sphingomyelin levels indicated organ-dependent responses. Decreased levels of sphingomyelins in the liver, nonmonotonic dose responses in the kidney, and irregular responses in the testis after PFOS exposure are observed. These lipid responses may be associated with alterations pertaining to phosphatidylcholine synthesis, fatty acid metabolism, membrane properties, and oxidative stress in the liver, kidney, and testis. Lipid responses in the liver could have contributed to the observed increase in liver to body weight ratios. The findings suggest potential toxicity and possible mechanisms associated with PFOS in multiple organs.